Gardner's syndrome
Gardner's syndrome | |
---|---|
Other names | Familial colorectal polyposis, Familial polyposis of the colon |
Specialty | Gastroenterology, oncology, medical genetics |
Gardner's syndrome (also known as Gardner syndrome, familial polyposis of the colon,
Desmoid tumors are fibrous tumors that usually occur in the tissue covering the intestines and may be provoked by surgery to remove the colon. The countless polyps in the colon predispose to the development of
The syndrome was first described in 1951.[5] There is no cure at this time, and in its more advanced forms, it is considered a terminal diagnosis with a life expectancy of 35–45 years; treatments are surgery and palliative care, although some chemotherapy has been tried with limited success.[6]
Cause
Gardner syndrome is caused by
Genetics
Gardner syndrome is inherited in an
Diagnosis
Gardner syndrome consists of adenomatous polyps of the gastrointestinal tract, Gardner fibromas, desmoid tumors, osteomas, epidermoid cysts, lipomas, dental abnormalities, and periampullary carcinomas. The incidence of the syndrome is 1:14,025 with an equal sex distribution. It is determined by the autosomal dominant familial polyposis coli gene (APC) on chromosome 5.[5][10]
Gardner syndrome can be identified based on oral findings, including multiple
Desmoid tumors arise most frequently from the aponeurosis of the rectus abdominal muscle of multiparous women. The extra-abdominal form is rare and desmoids of the breast may arise in the mammary gland or may occur as an extension of a lesion arising from the muscles of the chest wall. The incidence of mammary desmoid tumors is less than 0.2% of primary breast neoplasms. In Gardner's syndrome, the incidence ranges from 4% to 17%. Desmoid tumors associated with Gardner's syndrome have been shown to have an alteration of the β-catenin pathway and over express β-catenin.[5]
Treatment
There is no cure for Gardner Syndrome. Treatments focus on alleviating symptoms and reducing risk of cancer. Treatments for desmoid tumors may include surgery, NSAIDS, anti-estrogen medications, radiation therapy and chemotherapy.[6]
Eponym
The syndrome is named for Eldon J. Gardner (1909–1989), an American geneticist who first described it in 1951.[12]
See also
- Gorlin syndrome
- List of cutaneous conditions
- List of dental abnormalities associated with cutaneous conditions
- List of cutaneous neoplasms associated with systemic syndromes
References
- OCLC 1011508489.)
{{cite book}}
: CS1 maint: location missing publisher (link) CS1 maint: others (link - OCLC 1011508489.)
{{cite book}}
: CS1 maint: location missing publisher (link) CS1 maint: others (link - ^ a b c Online Mendelian Inheritance in Man (OMIM): 175100
- PMID 12613727. Archived from the originalon 2008-05-16. Retrieved 2009-08-23.
- ^ PMID 22370045.
- ^ a b "Gardner syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 17 April 2018.
- ^ "Gardner Syndrome". Cancer.net. American Society of Clinical Oncology. 2012-06-26. Retrieved 8 July 2016.
- ^ "Gardner syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-09-20.
- ^ "Gardner syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-09-20.
- PMID 31950474.
- ^ DeVita. Cancer, Principles and Practice of Oncology, 8th Ed. p. 1742.
- PMID 14902760.
External links
- Gardner syndrome at NIH's Office of Rare Diseases